Absci Corp reports results for the quarter ended in December - Earnings Summary

* Absci Corp  ABSI.OQ  reported a quarterly adjusted loss
of 25
cents​​ per share for the quarter ended in December, lower than
the same quarter last year, when the company reported EPS of -21
cents.  The mean expectation of six analysts for the quarter was
for a loss of 25 cents per share. Wall Street expected
results to range from -27 cents to -21 cents per share.
    * Revenue fell 78.3% to $338.00 thousand from a year ago;
analysts
expected $1.03 million. 
    * Absci Corp's reported EPS for the quarter was a loss of 25
cents​.
    * The company reported a quarterly loss of $23.55 million.
    * Absci Corp shares had risen by 17.9% this quarter.

FORECAST CHANGES
    * The mean earnings estimate of analysts had fallen by
about 9.8%
in the last three months.​ 
    * In the last 30 days, two analysts negatively revised
earnings
estimates

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 5 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "buy"

Wall Street's median 12-month price target for Absci Corp is
$8.00 
This summary was machine generated from LSEG data March 25 at
09:06 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Dec. 31 2023      -0.25          -0.25          Met
 Sep. 30 2023      -0.23          -0.24          Missed
 Jun. 30 2023      -0.24          -0.45          Missed
 Mar. 31 2023      -0.24          -0.26          Missed

Recent news on AbSci

See all news